Today, the FDA approved Pradaxa oral pellets and capsules to treat children with blood clots directly after they have been treated with a blood thinner given by injection for at least five days, and to prevent recurrent clots among patients who completed treatment for their first clot.
FDA Approves First Oral Blood Thinning Medication for Children
More from FDA News AlertsMore posts in FDA News Alerts »
- FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
- FDA In Brief: FDA Warns Firm with Over 15 Million Products Listed with FDA to Remove Unauthorized E-Cigarette Products from Market
- Coronavirus (COVID-19) Update: July 23, 2021
- Philips Respironics Recalls Certain Ventilators and BiPAP Machines Due to Potential Health Risks from PE-PUR Sound Abatement Foam